Erik Kinnmann has been the CEO of NeuroVive Pharmaceutical AB (STO:NVP) since 2016. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we’ll consider ...
Erik Kinnmann became the CEO of NeuroVive Pharmaceutical AB (STO:NVP) in 2016. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, ...
LUND, Sweden, Aug. 28, 2018 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that scientists at the company's research partner the Children's Hospital ...
Please provide your email address to receive an email when new articles are posted on . NeuroVive announced two research agreements designed to further develop the company’s new drug compounds in the ...
NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company, has signed a collaboration agreement with Isomerase Therapeutics to develop the molecules that were recently acquired from ...
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: "He will provide expertise and focus across the organization and establish solid partnerships that will enhance our R&D program further. His broad ...
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: "NeuroVive is right in a really interesting development phase, and I look forward to using my experience of similar positions to help move the company ...
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: NeuroVive Pharmaceutical AB (publ)(STO:NVP), the mitochondrial medicine company, has announced that the company’s development project NVP014 for the ...
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and mining exploration companies often lose money for years before finding success with ...
NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that a collaboration agreement has been signed with Karolinska Institutet, ...
NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced the appointment of Daniel Schale as Director of Communications. Daniel will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results